Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine

British Journal of Pharmacology

Volumn 129, Issue 4, 2000, Pages 645-652

  Coutts, Angela A ^a   Brewster, Nicola ^a   Ingram, Tracey ^a   Razdan, Raj K ^b   Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ORGANIX INC   (United States)

Author keywords

Cannabinoid receptor antagonists; Cannabinoid receptors; Guinea pig small intestine; Myenteric plexus; O 1184; SR141716A

Indexed keywords

1 DEOXYOCTYL 2' YNE DELTA 8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6' AZIDOHEX 2' ENE DELTA 8 TETRAHYDROCANNABINOL; 6' AZIDOHEX 2' YNE DELTA 8 TETRAHYDROCANNABINOL; AZIDE; CANNABINOID RECEPTOR; DELTA8 TETRAHYDROCANNABINOL; OCTYL 2' YNE DELTA 8 TETRAHYDROCANNABINOL; PARTIAL AGONIST; RIMONABANT; TETRAHYDROCANNABINOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENCY; DRUG STRUCTURE; GUINEA PIG; INTESTINE CONTRACTION; MALE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; STRUCTURE ACTIVITY RELATION;

EID: 0034095517     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703094     Document Type: Article

References (27)

1. Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J., Le Fur, G. & Casallas, P. (1997). A selective inverse agonist for central cannabinoid receptors inhibits mitogen-activated protein kinase activation stimulated by insulin-like growth factor 1. J. Biol. Chem., 272, 22330-22339.
2. Clark, R.B., Knoll, B.J. & Barber, R. (1999). Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol. Sci., 20, 270-286.
3. Colombo, G., Agabio, R., Lobina, C., Reali, R. & Gessa, G.L. (1998). Cannabinoid modulation of intestinal propulsion in mice. Eur. J. Pharmacol., 344, 67-69.
4. Colquhoun, D. (1971). Lectures on Biostatistics, Oxford: Oxford University Press.
5. Coutts, A.A., Fernando, S.R., Griffin, G., Nash, J.E. & Pertwee, R.G. (1995). Evidence that guinea-pig small intestine contains CB1 cannabinoid receptors and possibly also a cannabinoid receptor ligand. Br. J. Pharmacol., 116, 46P.
6. Coutts, A.A. & Pertwee, R.G. (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus-longitudinal muscle preparation. Br. J. Pharmacol., 121, 1557-1566.
7. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
8. Gessa, G.L., Casu, M.A., Carta, G. & Mascia, M.S. (1998). Cannabinoids decrease acctylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR141716A. Eur. J. Pharmacol., 355, 119-124.
9. Gifford, A.N. & Ashby, C.R. (1996). Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmac. Exp. Ther., 277, 1431-1436.
10. Griffin, G., Wray, E.J., Rorrer, W.K., Crocker, P.J., Ryan, W.J., Saha, B., Razdan, R.K., Martin, B.R. & Abood, M.E. (1999). An investigation into the structural determinants of cannabinoid receptor ligand efficacy. Br. J. Pharmacol., 126, 1575-1584.
11. Izzo, A.A., Mascolo, N., Borrelli, F. & Capasso, F. (1998). Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CBI receptors. Br. J. Pharmacol., 124, 1363-1368.
12. Kosterlitz, H.W. & Watt, A.J. (1968). Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (Naloxone). Br. J. Pharmacol. Chemother., 33, 266-276.
13. 1 receptor. Eur. J. Pharmacol., 334, R1-R2.
14. 2 receptors. Br. J. Pharmacol., 124, 619-622.
15. Martin, B.R., Thomas, B.F. & Razdan, R.K. (1995). Structural requirements for cannabinoid receptor probes. In: Pertwee, R.G. (ed). Cannabinoid Receptors, Academic Press: London, pp. 35-85.
16. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N., E. Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J. & Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
17. Paton, W.D.M. & Zar, M.A. (1968). The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J. Physiol., 194, 13-33.
18. Pertwee, R.G. & Fernando, S.R. (1996). Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br. J. Pharmacol., 118, 2053-2058.
19. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2198-2205.
20. Pertwee, R.G., Stevenson, L.A., Fernando, S.R. & Corbett, A.D. (1992). The production of cannabinoid tolerance in preparations of mouse vas deferens and of myenteric plexus-longitudinal muscle of mouse small intestime. Br. J. Pharmacol., 107, 365P.
21. Richardson, J.D., Aanonsen, L. & Hargreaves, K.M. (1997). SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol., 319, R3-R4.
22. Rinaldi-Carmona, M., Barth, F. Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Brelière, J.-C. & Le Fur, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letts., 350, 240-244.
23. Ross, R.A., Brockie, H.C., Fernando, S.R., Saha, B., Razdan, R.K. & Pertwee, R.G. (1998). Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine. Br. J. Pharmacol., 125, 1345-1351.
24. 8-tetrahydrocannabinol at cannabinoid receptors. Br. J. Pharmacol., 128, 735-743.
25. Rubino, T., Patrini, G., Massi, P., Fuzio, D., Vigano, D., Giagnoni, G. & Parolaro, D. (1998). Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J. Pharmacol. Exp. Ther., 285, 813-819.
26. Santucci, V., Storme, J.J., Soubrie, P. & Le Fur, G. (1996). Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci., 58, PL103-PL110.
27. Strangman, N.M., Patrick, S.L., Hohmann, A.G., Tsou, K. & Walker, J.M. (1998). Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res., 813, 323-328.